Skip to main content
. 2017;18(7):1855–1859. doi: 10.22034/APJCP.2017.18.7.1855

Table 2.

Distribution Frequencies for NFKB1 Promoter –94 del/ins ATTG and NFKB1A -826 C/T Genotypes in Controls and Patients.

Variable Controls (n=312) Patients (n=312) OR (95% CI) p value AOR (95% CI) p value
NFKB1 Genotype
 del/del 22 (7.05%) 18 (5.77%) 1 (ref) 1 (ref)
 del/ins 146 (46.79%) 162 (51.92%) 1.35 (0.69-2.62) 0.367 2.36 (1.06-5.23) 0.034
 ins/ins 144 (46.15%) 132 (42.31%) 1.12 (0.57-2.18) 0.738 1.75 (0.79-3.89) 0.164
 del/ins+ins/ins 290 (92.95%) 294 (94.23%) 1.23 (0.65-2.35) 0.514 2.04 (0.94-4.41) 0.068
NFKB1A Genotype
 CC 16 (5.13%) 32 (10.26%) 1 (ref) 1 (ref)
 CT 208 (66.67%) 199 (63.78%) 0.47 (0.25-0.89) 0.022 0.47 (0.22-0.98) 0.046
 TT 88 (28.21%) 81 (25.96%) 0.46 (0.23-0.90) 0.024 0.42 (0.19-0.92) 0.031
 CT+TT 296 (94.87%) 280 (89.94%) 0.47 (0.25-0.88) 0.018 0.46 (0.22-0.94) 0.034

OR, Odd Ratios; AOR, Adjusted Odd Ratios; ORs with 95% CIs were estimated by logistic regression models; AORs with 95% CIs were estimated by multiple logistic regression models after controlling for sex, age, tobacco chewing, alcohol consumption, and smoking status.